Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 15 (GPR15) is a member of the class A orphan GPCR family encoded by the GPR15 gene on chromosome 3q11.2-q13.1 in humans. It is mainly expressed on T cells (especially those trafficked to the colon), endothelial cells, and several epithelial and immune cell types. GPR15 mediates cell signaling involved in T cell chemotaxis to the gut, immune regulation, angiogenesis, and cytoprotection of endothelial cells. It acts as a co-receptor for HIV-1 and HIV-2, enabling viral entry into susceptible cells. GPR15 is implicated in the pathogenesis of inflammatory bowel diseases, chronic inflammatory disorders, certain cancers, and viral infections. Its unique ligand is C10orf99 (AP-57, sometimes called GPR15L). GPR15 is under investigation as a potential therapeutic target in inflammation, autoimmune diseases, and cancer, although no approved drugs directly target it to date.
Ligand-induced activation recruits G proteins, leading to intracellular signaling (ERK activation, chemotactic responses, etc.). Acts as HIV-1 and HIV-2 co-receptor facilitating entry of these viruses into target cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 15 (GPR15).